Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration

Journal of Leukocyte Biology

Volumn 78, Issue 1, 2005, Pages 62-69

  Porporatto, Carina ^a   Bianco, Ismael D ^b   Correa, Silvia G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cytokines; Immature dendritic cell; Mucosa

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD11B ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; CHITIN; CHITOSAN; CYTOKINE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DEACETYLATION; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE INDUCTION; HELPER CELL; HOMEOSTASIS; HUMORAL IMMUNITY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; LEUKOCYTE ACTIVATION; LYMPHOID TISSUE; MESENTERY LYMPH NODE; MICROENVIRONMENT; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PHENOTYPE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPLEEN; T LYMPHOCYTE ACTIVATION; TH2 CELL; TH3 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, SURFACE; CHEMOTAXIS, LEUKOCYTE; CHITOSAN; CYTOKINES; DENDRITIC CELLS; FEMALE; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MUCOUS MEMBRANE; PEYER'S PATCHES; PHENOTYPE; RATS; RATS, WISTAR; SPLEEN; T-LYMPHOCYTES; TH2 CELLS; UP-REGULATION;

EID: 22144431850     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0904541     Document Type: Article

References (55)

1. Mayer, L. (2003) Mucosal immunity. Pediatrics 111, 1595-1600.
2. Weiner, H. L. (2000) Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 106, 935-937.
3. Smith, K. M., Davidson, J. M., Garside, P. (2002) T-cell activation occurs simultaneously in local and peripheral lyniphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen, although tolerized T cells display a defect in cell division. Immunology 106, 144-158.
4. Mayer, L., Shao, L. (2004) Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4, 407-419.
5. Freytag, L. C., Clements, J. D. (1999) Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol. Immunol. 236, 215-236.
6. Holmgren, J., Czerkinsky, C., Eriksson, K., Mharandi, A. (2003) Mucosal immunization and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 (Suppl. 2), S89-S95.
7. O'Hagan, D. T. (1998) Recent advances in vaccine adjuvants for systemic and mucosal administration. J. Pharm. Pharmacol. 50, 1-10.
8. Tebbey, P. W., Scheuer, C. A., Peek, J. A., Zhu, D., LaPierre, N. A., Green, B. A., Phillips, E. D., Ibraghimov, A. R., Eldridge, J. H., Hancock, G. E. (2000) Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H. Vaccine 18, 2723-2734.
9. van Ginkel, F. W., Jackson, R. J., Yuki, Y., McGhee, J. R. (2000) Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165, 4778-4782.
10. Lang, D. (2001) Safety evaluation of toxin adjuvants delivered intranasally, http://www.niaid.nih.gov/dmid/enteric/intranasal.htm.
11. Johnson, D. A., Keegan, D. S., Sowell, C. G., Livesay, M. T., Johnson, C. L., Taubner, L. M., Harris, A., Myers, K. R., Thompson, J. D., Gustafson, G. L., Rhodes, M. J., Ulrich, J. T., Ward, J. R., Yorgensen, Y. M., Cantrell, J. L., Brookshire, V. G. (1999) 3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities. J. Med. Chem. 42, 4640-4649.
12. Johnson, D. A., Sowell, C. G., Johnson, C. L., Livesay, M. T., Keegan, D. S., Rhodes, M. J., Ulrich, J. T., Ward, J. R., Cantrell, J. L., Brookshire, V. G. (1999) Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs). Bioorg. Med. Chem. Lett. 9, 2273-2278.
13. Mason, K. W., Zhu, D., Scheuer, C. A., McMichael, J. C., Zlotnick, G. W., Green, B. A. (2004) Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 22, 3449-3456.
14. Illum, L. (1998) Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326-1331.
15. Mills, K. H., Cosgrove, C., McNeela, E. A., Sexton, A., Giemza, R., Jabbal-Gill, I., Church, A., Lin, W., Illum, L., Podda, A., Rappuoli, R., Pizza, M., Griffin, G. E., Lewis, D. J. (2003) Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A. Infect. Immun. 71, 726-732.
16. Sugano, M., Watanabe, S., Kishi, A., Izume, M., Ohtakara, A. (1988) Hypocholesterolemic action of chitosans with different viscosity in rats. Lipids 23, 187-191.
17. Lim, B. O., Yamada, K., Nonaka, M., Kuramoto, Y., Hung, P., Sugano, M. (1997) Dietary fibers modulate indices of intestinal immune function in rats. J. Nutr. 127, 663-667.
18. Illum, L., Jabbal-Gill, I., Hincheliffe, M., Fisher, A. N., Davis, S. S. (2001) Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51, 81-96.
19. Thanou, M., Verhorf, J. C., Junginger, H. E. (2001) Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52, 117-126.
20. Bacon, A., Makin, J., Sizer, P. J., Jabbal-Gill, I., Hincheliffe, M., Illum, L., Chatfield, S., Roberts, M. (2000) Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect. Immun. 68, 5764-5770.
21. van der Lubben, I. M., Verhoef, J. C., Borchard, G., Junginger, H. E. (2001) Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 14, 201-207.
22. van der Lubben, I. M., Kersten, G., Fretz, M. M., Beuvery, C., Coos Verhoef, J., Junginger, H. E. (2003) Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 21, 1400-1408.
23. Jabbal-Gill, I., Fisher, A. N., Rappuoli, R., Davis, S. S., Illum, L. (1998) Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine 16, 2039-2046.
24. Porporatto, C., Bianco, I. D., Cabanillas, A. M., Correa, S. G. (2004) Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines. Int. Immunol. 16, 433-441.
25. Moschos, S., Bramwell, V., Somavarapu, S., Alpar, H. (2004) Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunol. Cell Biol. 82, 628-637.
26. Peluso, G., Petillo, O., Ranieri, M., Santón, M., Ambrosio, L., Calabro, D., Avallone, B., Balsamo, G. (1994) Chitosan-mediated stimulation of macrophage function. Biomaterials 15, 1215-1220.
27. Porporatto, C., Bianco, I. D., Riera, C. M., Correa, S. G. (2003) Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages. Biochem. Biophys. Res. Commun. 304, 266-272.
28. Bianco, I. D., Balsinde, J., Beltramo, D. M., Castagna, L. F., Landa, C. A., Dennis, E. A. (2000) Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages. FEBS Lett. 466, 292-294.
29. Riedy, M. C. (1997) Characterization of murine macrophages. In Current Protocols in Immunology (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, W. Strober, eds.), New York, NY, Wiley & Sons, 14.2.8.
30. Lewis, D. E., Rickman, W. J. (1992) Methodology and quality control for flow cytometry. In Manual of Clinical Laboratory Immunology (N. R. Rose, E. C. De Macario, J-L. Fahey, H. Friedman, G. M. Penn, eds.), Washington, DC, American Society for Microbiology, 164.
31. Correa, S. G., Riera, C. M., Iribarren, P. (1997) Involvement of peritoneal dendritic cells in the induction of autoimmune prostatitis. J. Autoimmun. 10, 107-113.
32. Gutgemann, I., Fahrer, A. M., Altman, J. D., Davis, M. M., Chien, Y. (1998) Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8, 667-673.
33. Sun, J., Dirden-Kramer, B., Ito, K., Ernst, P. B., van Houten, N. (1999) Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162, 5868-5875.
34. Benson, J. M., Campbell, K. A., Guan, Z., Gienapp, I. E., Stuckman, S. S., Forsthuber, T., Whitacre, C. (2000) T-cell activation and receptor down-modulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 106, 1031-1038.
35. Unger, W. W. J., Hauet-Broere, F., Jansen, W., van Berkel, L. A., Kraal, G., Samsom, J. N. (2003) Early events in peripheral regulatory T cell induction via the nasal mucosa. J. Immunol. 171, 4592-4603.
36. Pala, P., Hussell, T., Openshaw, P. J. (2000) Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods 243, 107-124.
37. Zipris, D., Greiner, D. L., Malkani, S., Whalen, B., Mordes, J. P., Rossini, A. A. (1996) Cytokine gene expression in islets and thyroids of BB rats. J. Immunol. 156, 1315-1321.
38. ADsar, S. F., Landa, C. A., Bianco, I. D., Castagna, L. F., Beltramo, D. M. (2001) Hydrolysis of a chitosan-induced milk aggregate by pepsin, trypsin and pancreatic lipase. Biosci. Biotechnol. Biochem. 65, 2412-2418.
39. Hollak, C. E., van Weely, S., van Oers, M. H., Aerts, J. M. (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gancher disease. J. Clin. Invest. 93, 1288-1292.
40. Ruedl, C., Hubele, S. (1997) Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering. Eur. J. Immunol. 27, 1325-1330.
41. Iwasaki, A., Kelsall, B. L. (2001) Unique functions of CD11b+, CD8α+, and double-negative Peyer's patch dendritic cells. J. Immunol. 166, 4884-4890.
42. Kobayashi, H., Miura, S., Nagata, H., Tsuzuki, Y., Hokari, R., Ogino, T., Watanabe, C., Azuma, T., Ishii, H. (2004) In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J. Leukoc. Biol. 75, 434-442.
43. Brenan, M., Puklavec, M. (1992) The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J. Exp. Med. 175, 1457-1465.
44. Yrlid, U., MacPherson, G. (2003) Phenotype and function of rat dendritic cell subsets. APMIS 111, 756-765.
45. Neutra, M. R., Mantis, N. J., Krachenbuhl, J. P. (2001) Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2, 1004-1009.
46. Iwasaki, A., Kelsall, B. L. (1999) Freshly isolated Peyer's patches, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239.
47. Weiner, H. (2001) The mucosal milieu creates tolerogenic dendritic cells and Tr1 and Th3 regulatory cells. Nat. Immunol. 2, 671-672.
48. Ding, L., Shevach, E. M. (1992) IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148, 3133-3139.
49. Brand, D. D., Myers, L. K., Whittington, K. B., Lathman, K. A., Stuart, J. M., Kang, A. H., Rosloniec, E. F. (2002) Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J. Immunol. 168, 490-498.
50. Nishimura, K., Nishimura, S., Nishi, N., Saiki, I., Tokura, S., Azuma, I. (1984) Immunological activity of chitin and its derivatives. Vaccine 2, 93-99.
51. Johnson, A. G. (1994) Molecular adjuvants and immunomodulators: new approaches to immunization. Clin. Microbiol. Rev. 7, 277-289.
52. Hall, G., Lund, L., Lamb, J. R., Jarman, E. R. (2002) Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus Th2 immunity in allergic inflammation of the airways. J. Allergy Clin. Immunol. 110, 883-890.
53. Feng, J., Zhao, L., Yu, Q. (2004) Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem. Biophys. Res. Commun. 317, 414-420.
54. Hwang, S. M., Chen, C. Y., Chen, S. S., Chen, J. C. (2000) Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 271, 229-233.
55. Chou, T. C., Fu, E., Shen, E. C. (2003) Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysacharide-treated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 308, 403-407.